Suppr超能文献

用双(磺基琥珀酰亚胺)辛二酸酯将血管性血友病因子的单体39/34-kDa 分散酶片段(Leu-480/Val-481-Gly-718)与完整血小板上膜糖蛋白 Ibα链的N端区域交联。

Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate.

作者信息

Andrews R K, Gorman J J, Booth W J, Corino G L, Castaldi P A, Berndt M C

机构信息

Department of Medicine, University of Sydney, Westmead Hospital, NSW, Australia.

出版信息

Biochemistry. 1989 Oct 17;28(21):8326-36. doi: 10.1021/bi00447a010.

Abstract

A 39/34-kilodalton (kDa) monomeric dispase fragment of von Willebrand factor (vWF) has been purified by heparin affinity chromatography. Detailed structural analysis of the individual 39- and 34-kDa fragments indicated that they had identical amino acid sequences extending from Leu-480/Val-481 to Gly-718 with an intramolecular disulfide bond between Cys-509 and Cys-695. In addition to the binding site for heparin, the 39/34-kDa fragment also contained binding sites for collagen and for platelet membrane glycoprotein (GP) Ib. Unlike native vWF, the 39/34-kDa fragment bound to GP Ib without the requirement for a modulator but showed increased binding in the presence of botrocetin. The 39/34-kDa vWF fragment was cross-linked to intact human platelets by using the membrane-impermeable, homobifunctional cross-linking reagent bis(sulfosuccinimidyl) suberate. Two distinct cross-linked species of similar molecular weight (220/200 kDa, nonreduced; 190/175 kDa, reduced) were identified by SDS-polyacrylamide gel electrophoresis and autoradiography, consistent with the cross-linking of the 125I-labeled 39/34-kDa vWF fragment to GP Ib. The formation of these cross-linked species was enhanced 1.5-2.5-fold in the presence of the modulator botrocetin. The platelet membrane protein involved in cross-linking was shown unequivocally to be GP Ib since (i) neither cross-linked species was formed with Bernard-Soulier syndrome platelets, which genetically lack the GP Ib-IX complex, (ii) both cross-linked species were specifically immunoprecipitated by anti-GP Ib polyclonal and monoclonal antibodies, and (iii) the formation of the cross-linked species was completely inhibited only by those anti-GP Ib-IX complex monoclonal antibodies that inhibited vWF-GP Ib-IX complex interaction. Proteolysis of cross-linked platelets with endoproteinase Lys-C, which preferentially cleaves off the N-terminal peptide domain on the alpha-chain of GP Ib, indicated that the 39/34-kDa vWF fragment was cross-linked exclusively to this region of the GP Ib-IX complex.

摘要

通过肝素亲和层析法纯化了血管性血友病因子(vWF)的一种39/34千道尔顿(kDa)的单体性分散酶片段。对单个39 kDa和34 kDa片段的详细结构分析表明,它们具有相同的氨基酸序列,从Leu-480/Val-481延伸至Gly-718,在Cys-509和Cys-695之间存在分子内二硫键。除了肝素结合位点外,39/34 kDa片段还含有胶原蛋白和血小板膜糖蛋白(GP)Ib的结合位点。与天然vWF不同,39/34 kDa片段无需调节剂即可与GP Ib结合,但在存在蛇毒巴曲酶的情况下结合能力增强。使用膜不透性的同型双功能交联剂双(磺基琥珀酰亚胺基)辛二酸酯将39/34 kDa vWF片段与完整的人血小板交联。通过SDS-聚丙烯酰胺凝胶电泳和放射自显影鉴定出两种分子量相似的不同交联物种(220/200 kDa,非还原型;190/175 kDa,还原型),这与125I标记的39/34 kDa vWF片段与GP Ib的交联一致。在调节剂蛇毒巴曲酶存在的情况下,这些交联物种的形成增强了1.5至2.5倍。明确表明参与交联的血小板膜蛋白是GP Ib,因为(i)伯纳德-索利尔综合征血小板(遗传性缺乏GP Ib-IX复合物)未形成任何一种交联物种,(ii)两种交联物种均被抗GP Ib多克隆和单克隆抗体特异性免疫沉淀,并且(iii)仅被那些抑制vWF-GP Ib-IX复合物相互作用的抗GP Ib-IX复合物单克隆抗体完全抑制交联物种的形成。用内肽酶Lys-C对交联血小板进行蛋白水解,该酶优先切割GP Ibα链上的N末端肽结构域,表明39/34 kDa vWF片段仅与GP Ib-IX复合物的该区域交联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验